Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. Our goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.
Company Details
- Employees
- 21
- Founded
- 2000
- Address
- 888 7th Avenue,
- Phone
- (212) 651-6379
- jh****@****tal.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- aislingcapital.com
- Keywords
- Boston.
- HQ
- New York, NY
Aisling Capital Questions
Aisling Capital's helpline number is (212) 651-6379
Aisling Capital's website is aislingcapital.com
Aisling Capital's LinkedIn profile is https://www.linkedin.com/company/aisling-capital
Aisling Capital has
21 employees.
View email and phone details for 21
employees at Aisling Capital.
Aisling Capital's industry is
Venture Capital and Private Equity Principals
Aisling Capital's top competitors are
Healthcare Royalty,
Orbimed,
Ra Capital Management,
Casdin Capital, Llc,
Foresite Capital,
Tcgx,
Bicara Therapeutics,
Bridgebio,
Arch Venture Partners,
Atlas Venture.
Aisling Capital's support email address is jhoerrner@aislingcapital.com
Aisling Capital's categories are Venture Capital and Private Equity Principals
Aisling Capital's founding year is 2000
